A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Subscribe to Continue Reading
Uh oh–you've read all five of your free articles for this month.
Insider Online Only
$19.95/yr US PRICE
Stop “Gene Spills” Before They Happen
Proposal would use gene-editing patents to force scientists to open their labs to scrutiny.
On Patrol with America’s Top Bioterror Cop
Will garage gene editing unleash a biological plague? Special Agent Ed You is ready if it does.
How Network Neuroscience Is Creating a New Era of Mind Control
It might come down to the same network theory that rules computer science and economics.